SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.02 |
| Enterprise Value ($M) | -13.88 |
| Book Value ($M) | 12.22 |
| Book Value / Share | 3.11 |
| Price / Book | 0.25 |
| NCAV ($M) | 6.45 |
| NCAV / Share | 1.64 |
| Price / NCAV | 0.47 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.95 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.75 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.64 |
| Current Ratio | 2.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.07 |
| Assets | 24.84 |
| Liabilities | 12.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -28.88 |
| Net Income | -17.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -11.73 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 61,769 | 207,515 | 29.77 | |
| 101,952 | 388,886 | 26.22 | |
| 164,934 | 529,921 | 31.12 | |
| 122,893 | 466,626 | 26.34 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APM – Aptorum Group Limited | APRE – Aprea Therapeutics, Inc. |
| APTO – Aptose Biosciences Inc. | ARTL – Artelo Biosciences, Inc. |
| ASNS – Actelis Networks, Inc. |